Status:
ENROLLING_BY_INVITATION
Validation of SMS Protocol for HCC Screening in High-risk Patients
Lead Sponsor:
Erasmus Medical Center
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
The investigators will assess implementation of the proposed SMS protocol as a surveillance tool in patients at high risk of developing HCC in a prospective multicenter study.
Detailed Description
Over the past 20 years, the prevalence of HCC has been growing extensively. HCC makes up for 75-85% of primary liver cancers and has a poor prognosis with a 5-year survival rate lower than 20%. The in...
Eligibility Criteria
Inclusion
- Male and female patients above 18 years of age
- High-risk patients with cirrhosis and/or hepatitis
Exclusion
- Patients below the age of 18 years
- Patients who will not sign the informed consent form
- Patients with general contra-indications for undergoing MRI examination
Key Trial Info
Start Date :
November 7 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
470 Patients enrolled
Trial Details
Trial ID
NCT05429190
Start Date
November 7 2023
End Date
June 1 2026
Last Update
November 29 2023
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Academic Medical Center
Amsterdam, North Holland, Netherlands, 1105AZ
2
Medisch Spectrum Twente
Enschede, Overijssel, Netherlands, 7512KZ
3
Albert Schweitzer Ziekenhuis
Dordrecht, South Holland, Netherlands, 3318AT
4
Erasmus Medical Center
Rotterdam, South Holland, Netherlands, 3015GD